Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
Clinical trial NCT05691517 · RECRUITING
Trial details
- NCT number
- NCT05691517
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-12
- Primary completion
- 2026-10-15
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.